hemolytic disease therapy (AMRAD)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehemolytic disease therapy (AMRAD)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemolytic Streptococcus InfectionsAnemia, Hemolytic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCSL Innovation PTY Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCSL Innovation PTY Ltd
Active IndicationsN/A
Inactive IndicationsHemolytic Streptococcus InfectionsAnemia, Hemolytic

Other Information

ATC CodeN/A
Related LinksN/A